HHS Will Not Shy From Compliance Actions Arising From Part D’s Start-Up Phase, Leavitt Suggests
This article was originally published in The Pink Sheet Daily
Executive Summary
The department is currently investigating claims that some drug plans are not fulfilling their obligations, HHS Secretary Michael Leavitt says.